Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclic GMP-Dependent Protein Kinase Type I | 9 | 2022 | 15 | 3.520 |
Why?
|
| Cyclic GMP | 9 | 2022 | 92 | 3.110 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 4 | 2020 | 13 | 1.500 |
Why?
|
| Crystallography, X-Ray | 11 | 2021 | 353 | 1.370 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type II | 3 | 2016 | 6 | 1.150 |
Why?
|
| Cyclic AMP | 4 | 2016 | 249 | 0.860 |
Why?
|
| Models, Molecular | 8 | 2021 | 1070 | 0.800 |
Why?
|
| Azepines | 2 | 2021 | 62 | 0.780 |
Why?
|
| Plasmodium falciparum | 2 | 2020 | 62 | 0.730 |
Why?
|
| Protozoan Proteins | 2 | 2020 | 106 | 0.700 |
Why?
|
| Nitric Oxide | 2 | 2022 | 438 | 0.690 |
Why?
|
| Protein Multimerization | 3 | 2020 | 121 | 0.650 |
Why?
|
| Hydroxybenzoates | 1 | 2018 | 1 | 0.620 |
Why?
|
| Apoenzymes | 1 | 2016 | 3 | 0.570 |
Why?
|
| Thionucleotides | 1 | 2016 | 19 | 0.560 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 113 | 0.550 |
Why?
|
| Cystine | 1 | 2015 | 15 | 0.510 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 49 | 0.460 |
Why?
|
| Protein Structure, Tertiary | 5 | 2016 | 751 | 0.440 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 207 | 0.430 |
Why?
|
| Contraceptive Agents, Male | 2 | 2024 | 25 | 0.410 |
Why?
|
| Amino Acid Sequence | 7 | 2016 | 2680 | 0.370 |
Why?
|
| Protein Binding | 6 | 2021 | 1733 | 0.370 |
Why?
|
| Catalytic Domain | 4 | 2018 | 154 | 0.360 |
Why?
|
| Protein Conformation | 4 | 2018 | 833 | 0.340 |
Why?
|
| Phosphorylation | 4 | 2022 | 1614 | 0.330 |
Why?
|
| Binding Sites | 5 | 2021 | 1293 | 0.300 |
Why?
|
| Substrate Specificity | 2 | 2020 | 284 | 0.300 |
Why?
|
| Protein Domains | 2 | 2020 | 229 | 0.300 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 160 | 0.280 |
Why?
|
| Enzyme Stability | 2 | 2016 | 58 | 0.270 |
Why?
|
| Isoenzymes | 2 | 2020 | 222 | 0.260 |
Why?
|
| Protein Structure, Quaternary | 3 | 2020 | 98 | 0.260 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3869 | 0.260 |
Why?
|
| Contraception | 1 | 2024 | 60 | 0.220 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 123 | 0.210 |
Why?
|
| Leucine Zippers | 2 | 2014 | 17 | 0.210 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2021 | 137 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2022 | 409 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 263 | 0.190 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 110 | 0.180 |
Why?
|
| Triazoles | 1 | 2021 | 138 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 525 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 116 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 2 | 2011 | 5 | 0.170 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2020 | 647 | 0.160 |
Why?
|
| Arginine | 2 | 2013 | 303 | 0.160 |
Why?
|
| Chromatin | 1 | 2021 | 552 | 0.150 |
Why?
|
| Kinetics | 2 | 2016 | 1315 | 0.140 |
Why?
|
| Stereoisomerism | 1 | 2016 | 104 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 660 | 0.140 |
Why?
|
| Animals | 7 | 2024 | 33755 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2024 | 571 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2016 | 745 | 0.130 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 48 | 0.130 |
Why?
|
| DNA | 1 | 2021 | 1608 | 0.130 |
Why?
|
| Humans | 16 | 2024 | 122432 | 0.130 |
Why?
|
| ras Proteins | 1 | 2016 | 135 | 0.130 |
Why?
|
| Escherichia coli | 3 | 2021 | 978 | 0.130 |
Why?
|
| Transition Temperature | 1 | 2015 | 3 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 221 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2020 | 840 | 0.130 |
Why?
|
| COS Cells | 1 | 2016 | 273 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 287 | 0.130 |
Why?
|
| Ligands | 2 | 2021 | 536 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 102 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 166 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2016 | 459 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 1283 | 0.120 |
Why?
|
| Dimerization | 1 | 2014 | 144 | 0.120 |
Why?
|
| Nails, Malformed | 1 | 2013 | 8 | 0.110 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.110 |
Why?
|
| Hand Deformities, Congenital | 1 | 2013 | 89 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 339 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2014 | 808 | 0.100 |
Why?
|
| Leucine | 1 | 2013 | 309 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 139 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 239 | 0.100 |
Why?
|
| Exome | 2 | 2013 | 1038 | 0.100 |
Why?
|
| Craniofacial Abnormalities | 1 | 2013 | 243 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 316 | 0.100 |
Why?
|
| Apoproteins | 1 | 2011 | 20 | 0.100 |
Why?
|
| Structural Homology, Protein | 1 | 2011 | 26 | 0.090 |
Why?
|
| Calorimetry | 1 | 2011 | 56 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2587 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 238 | 0.090 |
Why?
|
| Testis | 2 | 2024 | 407 | 0.090 |
Why?
|
| Cell Line | 3 | 2021 | 2786 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 517 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1020 | 0.080 |
Why?
|
| Holoenzymes | 1 | 2007 | 10 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1758 | 0.070 |
Why?
|
| Tryptophan | 1 | 2007 | 92 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 167 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 198 | 0.070 |
Why?
|
| Adenine | 1 | 2007 | 99 | 0.070 |
Why?
|
| Computational Biology | 1 | 2011 | 794 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1614 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2007 | 200 | 0.070 |
Why?
|
| Intellectual Disability | 1 | 2013 | 1043 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 621 | 0.070 |
Why?
|
| Proteins | 1 | 2011 | 1044 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2016 | 4511 | 0.060 |
Why?
|
| Mutation | 2 | 2021 | 5776 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 2440 | 0.060 |
Why?
|
| Mice | 3 | 2024 | 17568 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 12 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2021 | 1370 | 0.060 |
Why?
|
| Phenotype | 1 | 2013 | 4214 | 0.060 |
Why?
|
| Gene Expression | 2 | 2021 | 1580 | 0.050 |
Why?
|
| Nanog Homeobox Protein | 1 | 2021 | 27 | 0.050 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2021 | 42 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 57 | 0.050 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2021 | 15 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 14 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 17 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2021 | 114 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 96 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 174 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 887 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 389 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 678 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 1354 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2021 | 969 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2016 | 7 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 3113 | 0.030 |
Why?
|
| Sildenafil Citrate | 1 | 2016 | 50 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 124 | 0.030 |
Why?
|
| Serine | 1 | 2016 | 174 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 761 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 991 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2013 | 14 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 85 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 140 | 0.030 |
Why?
|
| Male | 4 | 2024 | 59590 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2013 | 186 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2013 | 615 | 0.030 |
Why?
|
| Bacteriophage T4 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Trypanosoma | 1 | 2011 | 9 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2011 | 63 | 0.020 |
Why?
|
| Leishmania | 1 | 2011 | 27 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2011 | 73 | 0.020 |
Why?
|
| Klebsiella pneumoniae | 1 | 2011 | 72 | 0.020 |
Why?
|
| Protein Folding | 1 | 2011 | 214 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1574 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2011 | 348 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3293 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2313 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1890 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 881 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 865 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1114 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 18970 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 2042 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 8778 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 12334 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 13817 | 0.010 |
Why?
|
| Female | 2 | 2013 | 64958 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 25641 | 0.010 |
Why?
|
| Child | 1 | 2013 | 24105 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 28757 | 0.010 |
Why?
|